NL-OMON33957
已完成
不适用
DCE MRI in the follow-up of prostate cancer patients after radiotherapy; a matched case control stuy (Pilot) - Matched case control study.
niversitair Medisch Centrum Utrecht0 个研究点目标入组 200 人待定
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- prostate cancer
- 发起方
- niversitair Medisch Centrum Utrecht
- 入组人数
- 200
- 状态
- 已完成
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •\- Prostate cancer and therefore treated with external beam radiotherapy or I\-125 implantation in the last 10 years, with a minimum follow\-up of 2 years.
- •\- Written informed consent.
- •Specific inclusion criteria for the case group:
- •\- Biochemical failure as defined by the Phoenix criteria (nadir PSA level \+ 2 ng/mL)
- •\- Positive prostate biopsy results
排除标准
- •Contra\-indications for 3T MR imaging following the protocol of the department of Radiology UMCU.
- •Hormonal treatment \< 1 year before inclusion in this study.
- •Advanced kidney disease.;Specific exclusion for the case group:
- •Contra\-indication for prostate biopsy (for example oral anticoagulants use).
结局指标
主要结局
未指定
相似试验
已完成
不适用
Detecting local recurrent prostate cancer: MRI:patterns of post-prostatectomy recurrence and of its response to salvege radiotherapy using Enhanced and Dynamic Contrast Enhanced (DCE) MRIC61Malignant neoplasm of prostateDRKS00003469niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde33
尚未招募
不适用
Optimal Method for Prostate Cancer ScreeningKCT0009346Asan Medical Center60
招募中
不适用
The added value of MRI for detection of prostate cancer: validation with MR guided biopsies, fusion of MRI and transrectal ultrasound guided biopsies and TRUS guided biopsies.prostate cancerprostate carcinoma10038594NL-OMON32545niversitair Medisch Centrum Sint Radboud60
尚未招募
不适用
De toegevoegde waarde van magnetic resonance imaging in detectie van prostaatkanker.prostate cancer detection, diagnose prostaatkankerNL-OMON21521Radboud University Medical CentreDepartment of Radiology80
已完成
不适用
Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish SetupProstatic NeoplasmsNCT01640262Copenhagen University Hospital at Herlev170